243
Views
40
CrossRef citations to date
0
Altmetric
Research Articles

Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors

, , , , &
Pages 1782-1791 | Received 02 Oct 2015, Accepted 27 Mar 2016, Published online: 05 May 2016

References

  • Huang KJ, Li J, Liu YM, et al. Disposable immunoassay for hepatitis B surface antigen based on a graphene paste electrode functionalized with gold nanoparticles and a Nafion-cysteine conjugate. Microchim Acta 2012;177:419–26.
  • Saleh M, Soliman H, Haenen O, El-Matbouli M. Antibody-coated gold nanoparticles immunoassay for direct detection of Aeromonas salmonicida in fish tissues. J Fish Dis 2011;34:845–52.
  • Bhattacharyya S, Khan JA, Curran GL, et al. Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater 2011;23:5034–8.
  • Kang B, Mackey MA, El-Sayed MA. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 2010;132:1517–19.
  • Hoyer D, Bell GI, Berelowitz M, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995:86–8.
  • Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157–98.
  • Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36:228–47.
  • Taniyama Y, Suzuki T, Mikami Y, et al. Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J 2005;52:605–11.
  • Long JB. Spinal subarachnoid injection of somatostatin causes neurological deficits and neuronal injury in rats. Eur J Pharmacol 1988;149:287–96.
  • Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836–46.
  • Rivera JA, Alturaihi H, Kumar U. Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells. J Carcinog 2005;4:10.
  • Virgolini I, Traub T, Novotny C, et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 2002;8:1781–807.
  • Weiner RE, Thakur ML. Radiolabeled peptides in oncology: role in diagnosis and treatment. BioDrugs 2005;19:145–63.
  • Sharma K, Srikant CB. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 1998;76:259–66.
  • Reynaert H, Rombouts K, Vandermonde A, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004;53:1180–9.
  • Nowak KW, Strowski MZ, Switonska MM, et al. Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes. Int J Mol Med 2005;15:969--72.
  • Behr TM, Gratz S, Markus PM, et al. Enhanced bilateral somatostatin receptor expression in mediastinal lymph nodes (''chimney sign'') in occult metastatic medullary thyroid cancer: a typical site of tumour manifestation? Eur J Nucl Med 1997;24:184–91.
  • Roosterman D, Brune NEI, Kreuzer OJ, et al. Intracellular degradation of somatostatin-14 following somatostatin-receptor 3-mediated endocytosis in rat insulinoma cells. Febs J 2008;275:4728–39.
  • Wente W, Efanov AM, Treinies I, et al. The PDZ/coiled-coil domain containing protein PIST modulates insulin secretion in MIN6 insulinoma cells by interacting with somatostatin receptor subtype 5. Febs Let 2005;579:6305–10.
  • Roosterman D, Glassmeier G, Baumeister H, et al. A somatostatin receptor 1 selective ligand inhibits Ca2+ currents in rat insulinoma 1046-38 cells. Febs Let 1998;425:137–40.
  • Kubota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994;93:1321–5.
  • Patel YC. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997;20:348–67.
  • McMahon KA, Zajicek H, Li WP, et al. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. Embo J 2009;28:1001–15.
  • Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003;24:389–427.
  • Schweitzer P, Madamba S, Siggins GR. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 1990;346:464–7.
  • Colas B, Cambillau C, Buscail L, et al. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem 1992;207:1017–24.
  • Reubi J, Waser B, Foekens J, et al. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer 1990;46:416–20.
  • Nilsson O, Kolby L, Wangberg B, et al. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. Br J Cancer 1998;77:632–7.
  • Zhang D, Lee HF, Pettit SC, et al. Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol 2012;12:92.
  • Thomsen LB, Lichota J, Larsen TE, et al. Brain delivery systems via mechanism independent of receptor-mediated endocytosisi and adsorptive mediated endocytosis. Curr Pharm Biotechnol 2012;13:2349–54.
  • Wang H, Wu L, Reinhard BM. Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. ACS Nano 2012;6:7122–32.
  • Delehanty JB, Mattoussi H, Medintz IL. Delivering quantum dots into cells: strategies, progress and remaining issues. Anal Bioanal Chem 2009;393:1091–105.
  • Chen B, Liu QL, Zhang YL, et al. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots. Langmuir 2008;24:11866–71.
  • Kelf TA, Sreenivasan VKA, Sun J, et al. Non-specific cellular uptake of surface-functionalized quantum dots. Nanotechnology 2010;21:28.
  • Herrmann J, Bodmeier R. Degradation kinetics of somatostatin in aqueous solution. Drug Dev Ind Pharm 2003;29:1027–33.
  • Kimling J, Maier M, Okenve B, et al. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 2006;110:15700–7.
  • Frens G. Controlled nucleation for regulation of particle-size in monodisperse gold suspensions. Nat Phys Sci 1973;241:20–2.
  • Abdellatif AAH, Rasoul SAE, Osman S. Gold nanoparticles decorated with octreotide for somatostatin receptors targeting. J Pharm Sci & Res 2015;7:14–20.
  • Bhattacharjee RR, Mandal TK. Polymer-mediated chain-like self-assembly of functionalized gold nanoparticles. J Colloid Interface Sci 2007;307:288–95.
  • Elbakry A, Zaky A, Liebkl R, et al. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 2009;9:2059–64.
  • Chang CW, Chu SP, Tseng WL. Selective extraction of melamine using 11-mercaptoundecanoic acid-capped gold nanoparticles followed by capillary electrophoresis. J Chromatogr A 2010;1217:7800–6.
  • Lin SY, Tsai YT, Chen CC, et al. Two-step functionalization of neutral and positively charged thiols onto citrate-stabilized Au nanoparticles. J Phys Chem B 2004;108:2134–9.
  • Brizzi V, Corradini D. Rapid analysis of somatostatin in pharmaceutical preparations by HPLC with a micropellicular reversed-phase column. J Pharmaceut Biomed 1994;12:821–4.
  • Khalkhali-Ellis Z. An improved SDS-polyacrylamide gel electrophoresis for resolution of peptides in the range of 3.5-200kDa. Prep Biochem 1995;25:1–9.
  • Brandl F, Hammer N, Blunk T, et al. Biodegradable hydrogels for time-controlled release of tethered peptides or proteins. Biomacromolecules 2010;11:496–504.
  • Abdellatif AAH, et, al. Targeting of somatostatin receptors using quantum dots nanoparticles decorated with octreotide. J Nanomed Nanotechnol 2015;6:2.
  • Abdellatif AAH, et, al. Octreotide labelled fluorescein isothiocyanate for identification of somatostatin receptor subtype 2. Biochem Physiol 2015;4:2.
  • Seitz S, Schally AV, Gluck S, et al. Effective treatment of triple-negative breast cancer with targeted cytotoxic somatostatin analogue AN-162 (AEZS-124). J Clin Oncol 2009;27:15.
  • Keller PJ, Lin A, Arendt LM, et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010;12:R87.
  • Haiss W, Thanh NT, Aveyard J, Fernig DG. Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal Chem 2007;79:4215–21.
  • Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662–8.
  • Pereira-Lachataignerais J, Pons R, Panizza P, et al. Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chem Phys Lipids 2006;140:88–97.
  • Moraes CM, De Paula E, Rosa AH, Fraceto LF. Physicochemical stability of poly(lactide-co-glycolide) nanocapsules containing the local anesthetic bupivacaine. J Braz Chem Soc 2010;21:995–1000.
  • Aghajani M, Shahverdi AR, Amani A. The use of artificial neural networks for optimizing polydispersity index (PDI) in nanoprecipitation process of acetaminophen in microfluidic devices. AAPS PharmSciTech 2012;13:1293–301.
  • Lewis G, Li Y. Dependence of in vitro fatigue properties of PMMA bone cement on the polydispersity index of its powder. J Mech Behav Biomed Mater 2010;3:94–101.
  • Rosenfeld C, Serra C, Brochon C, Hadziioannou G. Influence of micromixer characteristics on polydispersity index of block copolymers synthesized in continuous flow microreactors. Lab Chip 2008;8:1682–7.
  • Vieville J, Tanty M, Delsuc MA. Polydispersity index of polymers revealed by DOSY NMR. J Magn Reson 2011;212:169–73.
  • Kaufman ED, Belyea J, Johnson MC, et al. Probing protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements. Langmuir 2007;23:6053–62.
  • Santander-Ortega MJ, Jodar-Reyes AB, Csaba N, et al. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J Colloid Interface Sci 2006;302:522–9.
  • Parab HJ, Huang JH, Lai TC, et al. Biocompatible transferrin-conjugated sodium hexametaphosphate-stabilized gold nanoparticles: synthesis, characterization, cytotoxicity and cellular uptake. Nanotechnology 2011;22:395706.
  • Wang G, Sun W. Optical limiting of gold nanoparticle aggregates induced by electrolytes. J Phys Chem B 2006;110:20901–5.
  • Aryal S, Remant BK, Narayan B, et al. Study of electrolyte induced aggregation of gold nanoparticles capped by amino acids. J Colloid Interface Sci 2006;299:191–7.
  • Aili D, Enander K, Rydberg J, et al. Aggregation-induced folding of a de novo designed polypeptide immobilized on gold nanoparticles. J Am Chem Soc 2006;128:2194–5.
  • Lee SH, Zhang ZP, Feng SS. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials 2007;28:2041–50.
  • Nishio K, Gokon N, Hasegawa M, et al. Identification of a chemical substructure that is immobilized to ferrite nanoparticles (FP). Colloids Surf B Biointerfaces 2007;54:249–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.